Berit Johansen
4PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 02, 2025
Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2 α for targeted cancer therapy.Felicity J Ashcroft, Asimina Bourboula, Nur Mahammad
|Oct 05, 2022
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A2 inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial.Vinzent Kevin Ortner, Berit Johansen, Kim Kilov
|Jan 23, 2019
Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis.A J Feuerherm, E A Dennis, B Johansen
|Oct 12, 2016
The emerging patent landscape of CRISPR-Cas gene editing technology.Knut J Egelie, Gregory D Graff, Sabina P Strand
Pageof 1
Frequent Collaborators
1 joint publications
Vinzent Kevin Ortner
1 joint publications
Astrid J Feuerherm
1 joint publications
Charlotte Pind Laugesen
1 joint publications
Maiken Lise Marcker Espersen
1 joint publications
Ionela Manole
1 joint publications
Ari Pall Isberg
1 joint publications
Anders Daniel Andersen
1 joint publications
Elin Rakvaag
1 joint publications
John R Zibert
1 joint publications
Merete Haedersdal
